Key Takeaways for AXT, Inc. Stock as of August 2026
- Whiplash Selloff: AXT stock dropped 16.67% to $73.81 just yesterday, August 10, unwinding most of Friday’s spike with no fresh company disclosure behind the reversal.
- Street Still Cautious: Coverage sits at 3 buys, 1 outperform and 2 holds, and the $91 mean target still sits 23% above Monday’s close.
- Model Sees Deep Upside: TIKR’s mid-case valuation puts AXT stock’s target price at $416, implying a 463% total return and a 48% annualized rate through the December 2031 realization date.
- Coverage Thins Into the Run: analyst count covering AXT stock’s price target slipped from 5 a year ago to 4 today, and two holds appeared on the sheet as the stock’s run accelerated, a sign the Street stopped chasing the tape even as the mean target kept climbing.
Curious how AXT stock stacks up against the rest of the compound semiconductor space? Compare AXT stock’s valuation on TIKR for free →
Why AXT Stock Reversed 17% Just Three Days After Its Rally Peaked
AXT (AXTI) stock fell 16.67% on Monday, August 10, closing at $73.81 after opening near $89 and trading as high as $90.39 intraday. The drop erased most of the gains from the prior session, when shares had jumped to an $88.58 close. No earnings report, regulatory filing, or company announcement preceded the selloff, and the move looks like profit-taking after a run that had gotten ahead of itself.
The rally itself traces to real news. AXT reported second-quarter results on July 30, and the numbers were the strongest in company history. Revenue hit $47.6 million, more than double the $18.0 million posted a year earlier, and non-GAAP net income swung to $11.9 million from a $585,000 loss in the first quarter. Indium phosphide, the compound semiconductor material used in optical transceivers for AI data centers, drove $30.7 million of that total, also a record. CEO Morris Young told analysts on the Q2 earnings call that demand is “moving faster than we can move,” with backlog exceeding $100 million and visibility now stretching three to four quarters out.
That backdrop explains why the stock spent the following days climbing. It does not explain Monday’s 17% air pocket. AXT signed long-term supply deals with Coherent and Lumentum in the weeks before earnings, each carrying multimillion-dollar prepayments tied to indium phosphide capacity through 2028 and beyond. Those agreements are locked in and unaffected by Monday’s price action.
But the stock had also diluted shareholders by roughly 18 million new shares since a secondary offering closed in April, equal to 28% of AXT’s 63.82 million shares now outstanding, and a run that took AXT stock from single digits to near $90 inside weeks left little room for anything short of flawless follow-through news
The thesis here does not hinge on a single disclosed catalyst. It hinges on whether the earnings-driven repricing was real and whether Monday’s pullback removed speculative froth or something closer to conviction. The indium phosphide backlog, the Lumentum and Coherent agreements, and the tripled 2026 capacity plan are all still intact after the drop.
The reversal does not undo AXT’s Q2 breakout. It resets the entry point for anyone who missed the run into $88, and it puts pressure on the Street’s targets to prove whether $91 was chasing the rally or pricing the business correctly.
Want the full financial history behind AXT’s indium phosphide ramp? See AXT stock’s earnings trend on TIKR for free →
AXT Stock’s Street Targets Show Analysts Growing Cautious Near the Top
The Street’s current view on AXT stock splits 3 buys, 1 outperform and 2 holds among the analysts tracked, and the mean target sits at $91.00 against Monday’s $73.81 close, a 23% gap. That target has not moved since the June 30 snapshot, even as the stock traded through an entire earnings cycle and a 17% one-day reversal.
The trend behind that number tells a fuller story. A year ago, on June 30, 2025, AXT stock closed at $2.09 with a mean target of $3.85 and five analysts contributing price targets. By March 31, 2026, the target had climbed to $30.75 as the stock reached $56.98, and coverage had already thinned to four analysts. Two holds joined the sheet at that same March snapshot, the first appearance of a hold rating in the entire table. Buys fell from four to three at the same time. Analysts kept raising dollar targets through the run, but they stopped adding conviction, trimming the ratio of buys to holds even as the mean target rose alongside the price.
That pattern matters against Monday’s drop. The Street was not chasing AXT stock blindly into $88; it had already built in hesitation before the reversal happened. The $91 target sitting above Monday’s close says analysts still see room, but the hold ratings embedded since March say that room comes with more skepticism than the headline upside number suggests.
TIKR Values AXT Stock at $416, Pricing a Multiyear Indium Phosphide Buildout
TIKR’s mid-case model values AXT stock at $416 by the December 2031 realization date, implying a 463% total return from Monday’s $73.81 close, or 48% annualized over roughly 5.4 years.
That annualized figure sits well above what investors typically demand from a compound semiconductor supplier, and it reflects a business TIKR expects to compound off a revenue base that just doubled in a single quarter. The gap between Monday’s close and the model’s target dwarfs even the Street’s already-wide 23% spread, underscoring how differently a multiyear capacity buildout gets priced than a quarterly estimate.
The model’s case rests on the same backlog and capacity story from Section 1: management’s plan to more than double indium phosphide capacity again in 2027, the Coherent and Lumentum prepayment agreements extending through 2028 and 2031, and a backlog Morris Young described as covering demand “going out to 2027.” None of that changed on Monday. The reversal traded on the absence of new news, not on any signal that the underlying ramp had slowed, which is exactly the gap TIKR’s model is pricing.
See exactly how TIKR built its $416 target for AXT stock. Access the full valuation model on TIKR for free →
Should You Invest in AXT, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up AXT, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track AXT, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze AXTI stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
